Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Surveillance HeartCare® Outcomes Registry
NCT03695601 · View on ClinicalTrials.gov ↗
Study Summary
This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.
Conditions Studied
Interventions
- OTHER Standard of Care
Study Locations (20)
California
- University of California San Diego — La Jolla
- Cedars-Sinai Medical Center — Los Angeles
- University of California, Los Angeles — Los Angeles
- University of Southern California — Los Angeles
- California Pacific Medical Center — San Francisco
- University of California San Fransisco Medical Center — San Francisco
- Stanford University — Stanford
Florida
- Memorial Healthcare System — Hollywood
- Mayo Clinic- Florida — Jacksonville
- University of Miami — Miami
- Advent Health — Orlando
- Tampa General Hospital — Tampa
Illinois
- Northwestern University — Chicago
- University of Chicago Medicine — Chicago
- Loyola University Medical Center — Maywood
Arizona
- Mayo Clinic Arizona — Phoenix
Arkansas
- Baptist Health Arkansas — Little Rock
Connecticut
- Yale New Haven — New Haven
District of Columbia
- Medstar Washington Hospital Center — Washington D.C.
Georgia
- Piedmont Heart Institute — Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,743 participants |
| Start Date | 2018-12-28 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03695601
The ClinicalTrials.gov registry entry for NCT03695601 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 2,743 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CareDx, which has 5 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Heart Transplant Rejection appearing as the primary indexed condition, and to 1 intervention — of which Standard of Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03695601 reports 20 study locations spanning 8 distinct geographic areas — top geographies include California, Florida, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03695601 about?
NCT03695601 is a clinical study titled "Surveillance HeartCare® Outcomes Registry". This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.
What is the current status of trial NCT03695601?
This trial is currently active not recruiting. The enrollment target is 2,743 participants. The study started on 2018-12-28. Estimated completion is 2026-11.
What conditions does trial NCT03695601 study?
This clinical trial studies the following conditions: Heart Transplant Rejection. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03695601?
The interventions under investigation include: Standard of Care (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03695601?
This trial is sponsored by CareDx, which has 5 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03695601 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.